ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Total du passif26.84 B26.66 B27.12 B26.47 B25.99 B25.58 BTotal des capitaux propres-322 M-240 M147 M356 M377 M-1.08 BTotal du passif et des capitaux propres26.52 B26.42 B27.27 B26.82 B26.37 B24.5 BDette totale18.94 B21.23 B21.74 B21.04 B20.82 B20.76 BDette nette18.94 B21.23 B19.13 B19.16 B19.28 B19.46 B
Bausch Health Companies Inc. Common Stock
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.